Evidence suggests that combining metformin with standard of care could increase survival and offer other benefits to patients with high-volume disease.

New research suggests that using the diabetes drug metformin for COVID-19 could help lower the risk of long Covid symptoms and improve its recovery time by as much as 41%, according to data presented ...

(Radiology)Multiple recent market withdrawals of drugs that received FDA accelerated approvals have raised concern about the ...

Individuals who use metformin were older, they were more likely to have uncontrolled diabetes, more likely to have obesity, chronic conditions, drug use -- all conditions associated with ...

Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making treatment ...

Janumet™ (MK-0431A) combines two OADs with complementary mechanisms of action to improve glycemic control, sitagliptin and metformin. The tablet was designed in order to be bioequivalent to ...

Drug sensitivity analysis highlights the effects of imatinib and metformin, revealing metformin’s unique role in modulating immune pathways, which supports its potential as a therapeutic agent ...